Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19
- PMID: 32353526
- PMCID: PMC7185011
- DOI: 10.1016/j.jgar.2020.04.024
Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19
Abstract
Cytokine release syndrome is prevalent in severe cases of COVID-19. In this syndrome, an uncontrolled response of immune system occurs. Extracorporeal blood purification has been proven to effectively remove the released inflammatory cytokines. Here, we reported a successful case to represent our experience of extracorporeal blood purification in a patient with severe COVID-19.
Keywords: Acute respiratory distress syndrome; COVID-19; Continues renal replacement therapy; Hemoperfusion.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Figures
References
-
- MacLaren G., Fisher D., Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA. 2020 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources